WallStreetZenWallStreetZen

NASDAQ: JANX
Janux Therapeutics Inc Stock Ownership - Who owns Janux Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Janux Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
David Alan CampbellPresident and CEO2026-01-028,072$13.73
$110.83kSell
Thomas DiraimondoChief Scientific Officer2026-01-022,505$13.73
$34.39kSell
Maria DobekVice President Accounting2026-01-021,462$13.73
$20.07kSell
Zachariah McIverChief Medical Officer2026-01-022,714$13.73
$37.26kSell
Andrew Hollman MeyerChief Business Officer2026-01-021,879$13.73
$25.80kSell
Charles M. WinterChief Technical Officer2026-01-022,401$13.73
$32.97kSell
Andrew Hollman MeyerChief Business Officer2025-12-01633$33.53
$21.22kSell
Andrew Hollman MeyerChief Business Officer2025-12-012,700$32.86
$88.71kSell
Andrew Hollman MeyerChief Business Officer2025-12-013,333$10.59
$35.30kBuy
Andrew Hollman MeyerChief Business Officer2025-11-143,333$10.59
$35.30kBuy

1 of 3

JANX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JANX insiders and whales buy or sell their stock.

JANX Shareholders

What type of owners hold Janux Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Avalon Ventures XI LP19.71%11,857,257$155.80MInsider
Jay Lichter18.36%11,040,308$145.07MInsider
Tighe Reardon14.34%8,628,172$113.37MInsider
Blackrock Inc6.78%4,080,200$53.61MInstitution
State Street Corp6.41%3,853,951$50.64MInstitution
Bregua Corp6.23%3,749,250$49.27MInsider
Vanguard Group Inc4.83%2,906,386$38.19MInstitution
Prosight Management LP3.98%2,392,523$31.44MInstitution
Alyeska Investment Group LP2.16%1,301,089$17.10MInstitution
Geode Capital Management LLC1.85%1,113,582$14.63MInstitution

1 of 3

JANX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JANX38.76%61.24%Net BuyingNet Selling
MPLT19.83%60.37%Net BuyingNet Selling
BCAX50.81%38.60%Net SellingNet Buying
GYRE1.88%98.12%Net Buying
ABUS23.35%76.65%
View Top Biotech Stocks

Janux Therapeutics Stock Ownership FAQ

Who owns Janux Therapeutics?

Janux Therapeutics (NASDAQ: JANX) is owned by 40.08% institutional shareholders, 63.32% Janux Therapeutics insiders, and 0.00% retail investors. Avalon Ventures XI LP is the largest individual Janux Therapeutics shareholder, owning 11.86M shares representing 19.71% of the company. Avalon Ventures XI LP's Janux Therapeutics shares are currently valued at $155.80M.

If you're new to stock investing, here's how to buy Janux Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.